Unimóvil UTRGV School of Medicine mobile clinic is in Houston, providing medical aid to hurricane victims

Translate to Spanish or other 102 languages!

By Jennifer L. Berghom

- Advertisement -

Mega Doctor News

HOUSTON, TEXAS – SEPT. 7, 2017 – A team from the UTRGV School of Medicine braved the elements to travel to the Houston area this week, to offer medical services to residents affected by Hurricane Harvey.

Led by Dr. Eron Manusov, assistant dean of Clinical Education and professor and chair of the UTRGV School of Medicine’s Department of Family and Community Medicine, the team of UTRGV School of Medicine healthcare professionals on Tuesday morning took the School of Medicine’s mobile clinic, Unimóvil, north to provide medical care throughout the week.

- Advertisement -

Team members included:

  • Dr. Eliana Costantino-Burgazzi, resident from Knapp Family Medicine.
  • Dr. Charles Lewis, resident from Doctors Hospital at Renaissance Family Medicine.
  • Lucy Rodriguez, nurse.
  • And Jesse Delgado, community health worker.

The team is working in partnership with UnitedHealth Foundation (UHF) to offer medical care to residents. UHF and the UTRGV School of Medicine have been working together for the past three years to provide healthcare to underserved areas; UHF provided funding for the mobile clinic.

In Houston, the Unimóvil team has been providing care for allergies, coughs and pneumonia, skin diseases, cuts, chronic diseases, diabetes and other illnesses.

Manusov said many patients have suffered loss and need refills on their medications. Many are experiencing anxiety from what they have experienced, among other concerns, he said.

- Advertisement -

South Texas Health System and UHF donated supplies, including tetanus shots and supplies for asthma.

From ground zero, Manusov Tweeted: “Water 4 feet high in houses destroyed. A lot (of) asthma, GI symptoms. Dr. (Charles) Lewis, Dr. (Eliana) Constantino and Dr. (Jesus) Garza a great team.”

Follow Dr. Manusov on Twitter: @eron_utrgv.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

Dr. Lisa Chapa Explains Why Not Every Breast Lump Is Cancer

 Discovering a lump in the breast can cause immediate concern, but many breast abnormalities are not cancerous, according to Dr. Lisa Chapa, a breast surgeon who explained how physicians distinguish benign conditions from breast cancer.

DHR Health Expands Behavioral Health Team with Dr. Alexandra Treviño, Psychiatrist

 DHR Health, the largest provider of specialty healthcare in the Rio Grande Valley, is pleased to announce that Dr. Alexandra Treviño, has joined its team of physicians.

New Breast Cancer Treatments Offer More Personalized Options for Patients in 2026

Advances in genetic testing and clinical research are giving physicians new ways to select breast cancer treatments based on individual patients' needs, according to Dr. Joseph Murray, senior medical director at Caris Life Sciences
- Advertisement -